Toggle navigation
Home
Search
Services
Blog
Contact
About
,
Raba, Inc., Washington, DC, United States
Search grants from
Search grants from Raba, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Micro-scale analysis of mesenchymal to epithelial transition in lung cancer
Oxygenase Side Reactions of Carbanion Forming Enzymes
Dopamine Antagonists in Treatment of Lesch Nyhan Disease
Contact, Adhesion and Friction: From Atomic Interactions to Macroscopic Behavior
Building a Cyberinfrastructure for the Critical Zone Exploration Network
Recently added grants:
Defining Siglec-6 and Siglec-8 function on effector cells of allergic diseases
Role of mTOR signaling in endothelial responses to Rickettsia rickettsii infection.
Siglec-targeted nanoparticles for treating mast cell mediated allergic disease
Post-transcriptional Gene Regulation by EBV SM Protein.
Human siglec ligands control mast cell and eosinophil mediated inflammation
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Indian Health Service (HRSA)
Type
Unknown (F18)
Project #
5F18IS002833-87
Application #
3562620
Study Section
Project Start
1987-10-01
Project End
1988-09-30
Budget Start
1987-10-01
Budget End
1988-09-30
Support Year
87
Fiscal Year
1987
Total Cost
Indirect Cost
Institution
Name
Raba, Inc.
Department
Type
DUNS #
City
Washington
State
DC
Country
United States
Zip Code
20011
Comments
Be the first to comment on this grant
